These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15868065)

  • 21. Optimizing the indication for breast-conservative surgery (BCS) in patients with locally-advanced breast cancer.
    Mazilu L; Suceveanu AI; Tomescu D; Ciufu N; Baz R; Suceveanu AP; Parepa IR; Tofolean DE; Voinea F
    Chirurgia (Bucur); 2013; 108(4):478-81. PubMed ID: 23958089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?
    Grobmyer SR; Mortellaro VE; Marshall J; Higgs GM; Hochwald SN; Mendenhall NP; Copeland EM; Cance WG
    J Am Coll Surg; 2008 May; 206(5):1045-50; discussion 1050-2. PubMed ID: 18471753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings.
    Alvarado-Cabrero I; Alderete-Vázquez G; Quintal-Ramírez M; Patiño M; Ruíz E
    Ann Diagn Pathol; 2009 Jun; 13(3):151-7. PubMed ID: 19433292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of patient satisfaction and provider trust after breast-conserving surgery.
    Waljee JF; Hu ES; Newman LA; Alderman AK
    Cancer; 2008 Apr; 112(8):1679-87. PubMed ID: 18327801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are mastectomy rates a reasonable quality measure of breast cancer surgery?
    McCahill LE; Privette AR; Hart MR; James TA
    Am J Surg; 2009 Feb; 197(2):216-21. PubMed ID: 18614141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer].
    Souchon R; Dunst J; Hartmann KA
    Strahlenther Onkol; 2006 Apr; 182(4):202-9. PubMed ID: 16622621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of mastectomy in breast conservation therapy candidates.
    Al-Refaie W; Kuerer HM; Khuwaja A; Perry A; Hunt KK; Feig B; Ames F; Ross M; Singletary SE; Meric-Bernstam F; Babiera GV
    Am J Surg; 2005 Oct; 190(4):602-5. PubMed ID: 16164931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast tattoos for planning surgery following neoadjuvant chemotherapy.
    Lannin DR; Grube B; Black DS; Ponn T
    Am J Surg; 2007 Oct; 194(4):518-20. PubMed ID: 17826070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
    Tinari N; Lattanzio R; Natoli C; Cianchetti E; Angelucci D; Ricevuto E; Ficorella C; Marchetti P; Alberti S; Piantelli M; Iacobelli S
    Clin Cancer Res; 2006 Mar; 12(5):1501-6. PubMed ID: 16533774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy.
    Thibault F; Nos C; Meunier M; El Khoury C; Ollivier L; Sigal-Zafrani B; Clough K;
    AJR Am J Roentgenol; 2004 Oct; 183(4):1159-68. PubMed ID: 15385323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
    Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
    Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?
    Grimsby GM; Gray R; Dueck A; Carpenter S; Stucky CC; Aspey H; Giurescu ME; Pockaj B
    Am J Surg; 2009 Oct; 198(4):500-4. PubMed ID: 19800455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer.
    Riedl O; Fitzal F; Mader N; Dubsky P; Rudas M; Mittlboeck M; Gnant M; Jakesz R
    Eur J Surg Oncol; 2009 Mar; 35(3):264-70. PubMed ID: 18706785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
    Liu CP; Shi L; Li Z
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.